Cleared Traditional

K885306 - NUPREP

K885306 is the FDA 510(k) clearance for NUPREP by Weaver & Co.. It is a Class 2 Cardiovascular device (product code DRX) cleared through the Traditional 510(k) pathway after a 58-day FDA review.

K885306 · Weaver & Co. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1989
Decision
58d
Days
Class 2
Risk

K885306 is an FDA 510(k) clearance for the NUPREP. Classified as Electrode, Electrocardiograph (product code DRX), Class II - Special Controls.

Submitted by Weaver & Co. (Aurora, US). The FDA issued a Cleared decision on February 23, 1989 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2360 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Weaver & Co. devices

Submission Details

510(k) Number K885306 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 27, 1988
Decision Date February 23, 1989
Days to Decision 58 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 125d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRX Electrode, Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2360
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRX Electrode, Electrocardiograph

All 84
Devices cleared under the same product code (DRX) and FDA review panel - the closest regulatory comparables to K885306.
M68 K KARAYA GUM DISP. MICROTAPE ECG ELECTRODE,68
K884982 · S & W Medico Teknik · Mar 1989
M55 K KARAYA GUM DISP. MICROTAPE ECG ELECTRODE, 55
K884983 · S & W Medico Teknik · Mar 1989
M40 K KARAYA GUM DISP. MICROTAPE ECG ELECTRODE, 40
K884984 · S & W Medico Teknik · Mar 1989
POLYHESIVE MONITORING AND DIAGNOSTIC ELECTRODES
K885262 · Valleylab, Inc. · Jan 1989
BARD TAB ECG MONITORING ELECTRODE
K890103 · C.R. Bard, Inc. · Jan 1989
BARD MULTI-TAC ECG MONITORING ELECTRODE
K884064 · C.R. Bard, Inc. · Oct 1988